A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE3

Conditions

Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Highlands Oncology Group, Springdale, Arkansas, United States

    Contact: Study coordinator (Principal Investigator)
  • Clinical Research Providence Medical Foundation, Fullerton, California, United States

    Contact: Study coordinator (Principal Investigator)
  • UCLA Hematology-Oncology, Los Angeles, California, United States

    Contact: Study coordinator (Principal Investigator)
  • UCSF Mission Bay Mission Hall, San Francisco, California, United States

    Contact: Study coordinator (Principal Investigator)
  • University of Miami Hospital and Clinics Sylvester Comprehensive Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Principal Investigator)
  • AdventHealth Orlando, Cancer Institute, Orlando, Florida, United States

    Contact: Study coordinator (Principal Investigator)
  • H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa, Florida, United States

    Contact: Study coordinator (Principal Investigator)
  • Rush MD Anderson Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Principal Investigator)
  • Baptist Health Lexington, Lexington, Kentucky, United States

    Contact: Study coordinator (Principal Investigator)
  • University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Principal Investigator)
  • John Hopkins School of Medicine, Baltimore, Maryland, United States

    Contact: Study coordinator (Principal Investigator)
  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Principal Investigator)
  • Henry Ford Health System, Detroit, Michigan, United States

    Contact: Study coordinator (Principal Investigator)
  • Mercy Clinic Oncology and Hematology Sindelar Cancer Center, St Louis, Missouri, United States

    Contact: Study coordinator (Principal Investigator)
  • University of Nebraska Medical Center, Omaha, Nebraska, United States

    Contact: Study coordinator (Principal Investigator)
  • Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

    Contact: Study coordinator (Principal Investigator)
  • Astera Cancer Care, East Brunswick, New Jersey, United States

    Contact: Study coordinator (Principal Investigator)
  • Hackensack Meridian Health Jsumc, Neptune City, New Jersey, United States

    Contact: Study coordinator (Principal Investigator)
  • Clinical Research Alliance, Inc, Lake Success, New York, United States

    Contact: Study coordinator (Principal Investigator)
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health Long Island, New York, New York, United States

    Contact: Study coordinator (Principal Investigator)
  • New York University Cancer Center - Laura and Isaac, New York, New York, United States

  • Montefiore Medical Center Prime, The Bronx, New York, United States

    Contact: Study coordinator (Principal Investigator)
  • Cleveland Clinic Mercy Hospital, Canton, Ohio, United States

    Contact: Study coordinator (Principal Investigator)
  • Oncology/Hematology Care Clinical Trials, Llc, Cincinnati, Ohio, United States

    Contact: Study coordinator (Principal Investigator)
  • Providence Portland Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Principal Investigator)
  • THE WEST CLINIC, PLLC dba West Cancer Center, Germantown, Tennessee, United States

    Contact: Study coordinator (Principal Investigator)
  • Houston Methodist Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Principal Investigator)
  • University of Texas Md Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Principal Investigator)
  • Texas Oncology, P.A. - Tyler, Tyler, Texas, United States

    Contact: Study coordinator (Principal Investigator)
  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Principal Investigator)
  • Ballarat Base Hospital, Ballarat, Australia

    Contact: Study coordinator (Principal Investigator)
  • Flinders Medical Centre (Fmc), Bedford Park, Australia

    Contact: Study coordinator (Principal Investigator)
  • Chris O Brien Lifehouse, Camperdown, Australia

    Contact: Study coordinator (Principal Investigator)
  • Sunshine Hospital, St Albans, Australia

    Contact: Study coordinator (Principal Investigator)
  • St John of God Subiaco Hospital, Subiaco, Australia

  • Townsville Cancer Centre, Townsville, Australia

    Contact: Study coordinator (Principal Investigator)
  • Princess Alexandra Hospital, Woolloongabba, Australia

    Contact: Study coordinator (Principal Investigator)
  • Landeskrankenhaus Feldkirch, Feldkirch, Austria

    Contact: Study coordinator (Principal Investigator)
  • Landesklinikum Krems, Krems, Austria

    Contact: Study coordinator (Principal Investigator)
  • Kepler University Hospital, Linz, Austria

    Contact: Study coordinator (Principal Investigator)
  • Wiener Gesundheitsverband Klinik Penzing, Vienna, Austria

    Contact: Study coordinator (Principal Investigator)
  • Klinik Floridsdorf, Vienna, Austria

    Contact: Study coordinator (Principal Investigator)
  • Cliniques Universitaires Saint-Luc, Brussels, Belgium

    Contact: Study coordinator (Principal Investigator)
  • Universitair Ziekenhuis Antwerpen, Edegem, Belgium

    Contact: Study coordinator (Principal Investigator)
  • Jessa Ziekenhuis Hospital, Hasselt, Belgium

    Contact: Study coordinator (Principal Investigator)
  • Centre Hospitalier Universitaire de Liege, Liège, Belgium

    Contact: Study coordinator (Principal Investigator)
  • AZ DELTA, Roeselare, Belgium

    Contact: Study coordinator (Principal Investigator)
  • Chu Ucl Namur, Yvoir, Belgium

    Contact: Study coordinator (Principal Investigator)
  • Departmento de Pesquisa Clinica- Hospital de Amor de Barretos, Barretos, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Cepon - Centro de Pesquisas Oncolăgicas de Santa Catarina, Florianópolis, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Clínica de Neoplasias Litoral, Itajaí, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Hospital São Lucas Da Pucrs, Porto Alegre, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Cepho Centro de Estudos E Pesquisas de Hematologia E Oncologia, Santo André, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto, São José do Rio Preto, Brazil

    Contact: Study coordinator (Principal Investigator)
  • ICESP Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira, São Paulo, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Hospital Sirio-Libanes, São Paulo, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Hospital Beneficăncia Portuguesa de Săo Paulo, São Paulo, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Hospital Alemão Oswaldo Cruz, São Paulo, Brazil

    Contact: Study coordinator (Principal Investigator)
  • A. C. Camargo Cancer Center, São Paulo, Brazil

    Contact: Study coordinator (Principal Investigator)
  • William Osler Health System - Brampton Civic Hospital, Brampton, Canada

  • Cross Cancer Institute, Edmonton, Canada

    Contact: Study coordinator (Principal Investigator)
  • Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Québec, Canada

    Contact: Study coordinator (Principal Investigator)
  • Princess Margaret Cancer Center, Toronto, Canada

    Contact: Study coordinator (Principal Investigator)
  • Cancercare Manitoba, Winnipeg, Canada

    Contact: Study coordinator (Principal Investigator)
  • China-Japan Friendship Hospital, Beijing, China

  • Beijing Cancer Hospital, Beijing, China

    Contact: Study coordinator (Principal Investigator)
  • Beijing Chest Hospital,Capital Medical University, Beijing, China

    Contact: Study coordinator (Principal Investigator)
  • Jilin Province Tumor Hospital, Changchun, China

    Contact: Study coordinator (Principal Investigator)
  • Hunan Cancer Hospital, Changsha, China

    Contact: Study coordinator (Principal Investigator)
  • Sichuan Cancer Hospital, Chengdu, China

    Contact: Study coordinator (Principal Investigator)
  • West China Hospital, Sichuan University, Chengdu, China

    Contact: Study coordinator (Principal Investigator)
  • Chongqing University Cancer Hospital, Chongqing, China

    Contact: Study coordinator (Principal Investigator)
  • Harbin Medical University Cancer Hospital, Haerbin, China

    Contact: Study coordinator (Principal Investigator)
  • The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

    Contact: Study coordinator (Principal Investigator)
  • Zhejiang Cancer Hospital, Hangzhou, China

    Contact: Study coordinator (Principal Investigator)
  • The Second Affiliated Hospital of Nanchang University, Jiangxi, China

    Contact: Study coordinator (Principal Investigator)
  • Shandong Cancer Hospital, Jinan, China

    Contact: Study coordinator (Principal Investigator)
  • Linyi Cancer Hospital, Linyi, China

    Contact: Study coordinator (Principal Investigator)
  • The Second Peoples Hospital of Neijiang, Neijiang, China

    Contact: Study coordinator (Principal Investigator)
  • Yantai Yuhuangding Hospital, Shandong, China

  • Fudan University Shanghai Cancer Center, Shanghai, China

    Contact: Study coordinator (Principal Investigator)
  • Liaoning Cancer Hospital & Institute, Shenyang, China

  • Tianjin Medical University Cancer Institute & Hospital, Tianjin, China

    Contact: Study coordinator (Principal Investigator)
  • The Affiliated Cancer Hospital of Xinjiang Medical University, Ürümqi, China

    Contact: Study coordinator (Principal Investigator)
  • Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    Contact: Study coordinator (Principal Investigator)
  • Huazhong University of Science and Technology - Tongji Medical College - Tongji Hospital Tjh, Wuhan, China

    Contact: Study coordinator (Principal Investigator)
  • Hubei Cancer Hospital, Wuhan, China

    Contact: Study coordinator (Principal Investigator)
  • The First Affiliated Hospital of Xiân Jiaotong University, Xi'an, China

  • Xiangyang Central Hospital, Xiangyang, China

    Contact: Study coordinator (Principal Investigator)
  • Henan Cancer Hospital, Zhengzhou, China

    Contact: Study coordinator (Principal Investigator)
  • Krajska Nemocnice Liberec A.S., Liberec, Czechia

    Contact: Study coordinator (Principal Investigator)
  • Fakultni Nemocnice Olomouc, Olomouc, Czechia

    Contact: Study coordinator (Principal Investigator)
  • Fakultni Thomayerova Nemocnice, Prague, Czechia

    Contact: Study coordinator (Principal Investigator)
  • Institut Sainte Catherine, Avignon, France

    Contact: Study coordinator (Principal Investigator)
  • Chu Bordeaux, Bordeaux, France

    Contact: Study coordinator (Principal Investigator)
  • Centre Hospitalier Intercommunal de Crăteil, Créteil, France

    Contact: Study coordinator (Principal Investigator)
  • Institut Cœur Poumon CHU de Lille, Lille, France

  • Chu Limoges - Hopital Du Cluzeau, Limoges, France

    Contact: Study coordinator (Principal Investigator)
  • Centre Léon Bérard, Lyon, France

    Contact: Study coordinator (Principal Investigator)
  • Assistance Publique-Hăpitaux de Marseille, Marseille, France

    Contact: Study coordinator (Principal Investigator)
  • Hopital Arnaud de Villeneuve, Montpellier, France

    Contact: Study coordinator (Principal Investigator)
  • Institut Régional Du Cancer de Montpellier, Montpellier, France

    Contact: Study coordinator (Principal Investigator)
  • Ch de Mulhouse - Hăpital Emile Muller, Mulhouse, France

    Contact: Study coordinator (Principal Investigator)
  • Institut Curie - Site de Paris, Paris, France

    Contact: Study coordinator (Principal Investigator)
  • Hopital Tenon, Paris, France

    Contact: Study coordinator (Principal Investigator)
  • Chu Rennes - Hopital Pontchaillou, Rennes, France

  • CHU de Saint Etienne, Saint-Etienne, France

    Contact: Study coordinator (Principal Investigator)
  • Chu Nantes - Hăpital Guillaume Et Renă Laănnec, Saint-Herblain, France

    Contact: Study coordinator (Principal Investigator)
  • Institut de Cancerologie de La Loire, Saint-Priest-en-Jarez, France

    Contact: Study coordinator (Principal Investigator)
  • Hăpital Foch, Suresnes, France

    Contact: Study coordinator (Principal Investigator)
  • Institut Gustave Roussy, Villejuif, France

    Contact: Study coordinator (Principal Investigator)
  • Evangelische Lungenklinik Berlin, Berlin, Germany

    Contact: Study coordinator (Principal Investigator)
  • Helios Klinikum Erfurt, Erfurt, Germany

    Contact: Study coordinator (Principal Investigator)
  • Universtitaetsklinikum Essen, Essen, Germany

    Contact: Study coordinator (Principal Investigator)
  • Krankenhaus Nordwest Gmbh, Frankfurt, Germany

    Contact: Study coordinator (Principal Investigator)
  • Universitaetsklinikum Frankfurt Goethe-Universitaet, Frankfurt am Main, Germany

    Contact: Study coordinator (Principal Investigator)
  • Asklepios Fachkliniken Muenchen-Gauting, Gauting, Germany

    Contact: Study coordinator (Principal Investigator)
  • Srh Wald-Klinikum Gera Gmbh, Gera, Germany

    Contact: Study coordinator (Principal Investigator)
  • UNIVERSITATSKLINIKUM GIeBEN UND MARBURG GMBH, Giessen, Germany

    Contact: Study coordinator (Principal Investigator)
  • Asklepios Klinik Harburg, Hamburg, Germany

    Contact: Study coordinator (Principal Investigator)
  • Lki Lungenfachklinik Immenhausen, Immenhausen, Germany

    Contact: Study coordinator (Principal Investigator)
  • Staedtisches Krankenhaus Kiel, Kiel, Germany

    Contact: Study coordinator (Principal Investigator)
  • Johannes Wesling Klinikum Minden, Minden, Germany

    Contact: Study coordinator (Principal Investigator)
  • Pius-Hospital Oldenburg, Oldenburg, Germany

    Contact: Study coordinator (Principal Investigator)
  • Universitaetsklinikum Ulm, Ulm, Germany

    Contact: Study coordinator (Principal Investigator)
  • 'Henry Dynant' Hospital Center, Athens, Greece

    Contact: Study coordinator (Principal Investigator)
  • General Hospital of Athens of Chest Diseases 'Sotiria', Athens, Greece

    Contact: Study coordinator (Principal Investigator)
  • General Hospital of Athens Alexandra, Athens, Greece

    Contact: Study coordinator (Principal Investigator)
  • University General Hospital "Attikon", Chaïdári, Greece

    Contact: Study coordinator (Principal Investigator)
  • University General Hospital of Larissa, Larissa, Greece

    Contact: Study coordinator (Principal Investigator)
  • General Hospital of Patra Agios Andreas, Pátrai, Greece

    Contact: Study coordinator (Principal Investigator)
  • Metropolitan Hospital, Piraeus, Greece

    Contact: Study coordinator (Principal Investigator)
  • St Luke'S Hospital, Thessaloniki, Greece

    Contact: Study coordinator (Principal Investigator)
  • Semmelweis Egyetem, Budapest, Hungary

    Contact: Study coordinator (Principal Investigator)
  • Orszagos Koranyi Pulmonologiai Intezet, Budapest, Hungary

    Contact: Study coordinator (Principal Investigator)
  • Orszagos Onkologiai Intezet, Budapest, Hungary

    Contact: Study coordinator (Principal Investigator)
  • Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz, Győr, Hungary

    Contact: Study coordinator (Principal Investigator)
  • Bács-Kiskun Vármegyei Oktatókórház, Kecskemét, Hungary

    Contact: Study coordinator (Principal Investigator)
  • Istituto Tumori Giovanni Paolo Ii Irccs Ospedale Oncologico Bari, Bari, Italy

    Contact: Study coordinator (Principal Investigator)
  • Humanitas Gavazzeni, Bergamo, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia (Presidio Spedali Civili), Brescia, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Ospedaliera Universitaria Policlinico - Vittorio Emanuele (Presidio Gaspare Rodolico), Catania, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Ospedaliero Universitaria Renato Dulbecco, Catanzaro, Italy

    Contact: Study coordinator (Principal Investigator)
  • Istituto Nazionale Per La Ricerca Sul Cancro Di Genova, Genova, Italy

    Contact: Study coordinator (Principal Investigator)
  • Ospedale San Raffaele, Milan, Italy

    Contact: Study coordinator (Principal Investigator)
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Contact: Study coordinator (Principal Investigator)
  • IEO Istituto Europeo di Oncologia, Milan, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Socio Sanitaria Territoriale Di Monza (Presidio San Gerardo), Monza, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Ospedaliera Universitaria- Universită Degli Studi Della Campania Âluigi Vanvitelliâ, Naples, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Ospedaliero Universitaria Di Parma, Parma, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Ospedaliera Di Perugia Ospedale S. Maria Della Misericordia, Perugia, Italy

    Contact: Study coordinator (Principal Investigator)
  • Istituto Nazionale Tumori Regina Elena Irccs, Roma, Italy

    Contact: Study coordinator (Principal Investigator)
  • Istituto Clinico Humanitas, Rozzano, Italy

    Contact: Study coordinator (Principal Investigator)
  • Centro Ricerche Cliniche Di Verona S.R.L., Verona, Italy

    Contact: Study coordinator (Principal Investigator)
  • National Cancer Center Hospital, Chūōku, Japan

    Contact: Study coordinator (Principal Investigator)
  • Kyushu University Hospital, Fukuoka, Japan

    Contact: Study coordinator (Principal Investigator)
  • Kansai Medical University Hospital, Hirakata-shi, Japan

    Contact: Study coordinator (Principal Investigator)
  • National Cancer Center Hospital East, Kashiwa, Japan

    Contact: Study coordinator (Principal Investigator)
  • The Cancer Institute Hospital of Jfcr, Kōtoku, Japan

    Contact: Study coordinator (Principal Investigator)
  • National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan

    Contact: Study coordinator (Principal Investigator)
  • Shizuoka Cancer Center, Nakatogari, Japan

    Contact: Study coordinator (Principal Investigator)
  • Okayama University Hospital, Okayama, Japan

    Contact: Study coordinator (Principal Investigator)
  • Kindai University Hospital, Osaka-Sakai, Japan

    Contact: Study coordinator (Principal Investigator)
  • Kitasato University Hospital, Sagamihara, Japan

    Contact: Study coordinator (Principal Investigator)
  • National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan

    Contact: Study coordinator (Principal Investigator)
  • Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Japan

    Contact: Study coordinator (Principal Investigator)
  • Wakayama Medical University Hospital, Wakayama, Japan

    Contact: Study coordinator (Principal Investigator)
  • Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, Netherlands

    Contact: Study coordinator (Principal Investigator)
  • Netherlands Cancer Institute, Amsterdam, Netherlands

    Contact: Study coordinator (Principal Investigator)
  • Maastricht University Medical Center, Maastricht, Netherlands

    Contact: Study coordinator (Principal Investigator)
  • Etz Elisabeth, Tilburg, Netherlands

  • Centrum Onkologii Im. Prof. F. Lukaszczyka W Bydgoszczy, Bydgoszcz, Poland

    Contact: Study coordinator (Principal Investigator)
  • Instytut Centrum Zdrowia Matki Polki, Lodz, Poland

    Contact: Study coordinator (Principal Investigator)
  • Mazowieckie Centrum Leczenia Chorob Pluc I Gruzlicy, Otwock, Poland

    Contact: Study coordinator (Principal Investigator)
  • Szpital Specjalistyczny W Prabutach, Prabuty, Poland

    Contact: Study coordinator (Principal Investigator)
  • Provita Prolife, Tomaszów Mazowiecki, Poland

    Contact: Study coordinator (Principal Investigator)
  • Centro Hospitalar E Universitărio de Coimbra E.P.E., Coimbra, Portugal

    Contact: Study coordinator (Principal Investigator)
  • Hospital Da Senhora Da Oliveira Guimarăes, Guimarães, Portugal

    Contact: Study coordinator (Principal Investigator)
  • Hospital Da Luz, Lisbon, Portugal

    Contact: Study coordinator (Principal Investigator)
  • Centro Hospitalar de Lisboa Norte, E.P.E. - Hospital Pulido Valente, Lisbon, Portugal

    Contact: Study coordinator (Principal Investigator)
  • Centro Hospitalar Do Porto, E.P.E. - Hospital de Santo António, Porto, Portugal

    Contact: Study coordinator (Principal Investigator)
  • S.C Radiotherapy Center Cluj S.R.L, Bucharest, Romania

    Contact: Study coordinator (Principal Investigator)
  • Institutul Oncologic 'Prof. Dr. Ion Chiricuta' Cluj Napoca, Cluj-Napoca, Romania

    Contact: Study coordinator (Principal Investigator)
  • S.C Centrul de Oncologie Sfantul Nectarie Craiova, Craiova, Romania

    Contact: Study coordinator (Principal Investigator)
  • S.C. Sigmedical Services Srl, Suceava, Romania

    Contact: Study coordinator (Principal Investigator)
  • Chungbuk National University Hospital, Cheongju-si, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Kyungpook National University Chilgok Hospital, Daegu, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Seoul National University Bundang Hospital, Seongnam-si, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Severance Hospital, Yonsei University Health System, Seoul, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Samsung Medical Center, Seoul, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Seoul National University Hospital, Seoul, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Asan Medical Center, Seoul, South Korea

    Contact: Study coordinator (Principal Investigator)
  • The Catholic University of Korea, St. Vincent'S Hospital, Suwon, South Korea

  • Ajou University Hospital, Suwon, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Hospital Clinic de Barcelona, Barcelona, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital de La Santa Creu I Sant Pau, Barcelona, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitari Vall D'Hebron, Barcelona, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario Reina Sofia, Córdoba, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario Ciudad de Jaen, Jaén, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital de Especialidades de Jerez de La Frontera, Jerez de la Frontera, Spain

    Contact: Study coordinator (Principal Investigator)
  • Ico L'Hospitalet - Hospital Duran I Reynals, L'Hospitalet de Llobregat, Spain

    Contact: Study coordinator (Principal Investigator)
  • Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital General Universitario Gregorio Marañon, Madrid, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario Ramon Y Cajal, Madrid, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario 12 de Octubre, Madrid, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario La Paz, Madrid, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Regional Universitario de Malaga, Málaga, Spain

  • Hospital Universitario Virgen Macarena, Seville, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario Virgen Del Rocio, Seville, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario Nuestra Señora de Valme, Seville, Spain

    Contact: Study coordinator (Principal Investigator)
  • Inselspital - Universitaetsspital Bern, Bern, Switzerland

    Contact: Study coordinator (Principal Investigator)
  • Kantonsspital St. Gallen, Sankt Gallen, Switzerland

    Contact: Study coordinator (Principal Investigator)
  • Hfr Fribourg/Kantonsspital Fribourg, Villars-sur-Glâne, Switzerland

    Contact: Study coordinator (Principal Investigator)
  • Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • China Medical University Hospital, Taichung, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • Taichung Veterans General Hospital, Taichung, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • National Cheng Kung University Hospitalx, Tainan, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • National Taiwan University Cancer Centre, Taipei, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • Taipei Medical University Hospital, Taipei, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • Taipei Veterans General Hospital, Taipei, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • Chang Gung Memorial Hospital, Taoyuan City, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Ankara Bilkent City Hospital, Ankara, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Dicle University, Medical Faculty, Diyarbakır, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Goztepe Prof Dr Suleyman Yalcin City Hospital, Istanbul, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty, Istanbul, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Medipol University Medical Faculty, Istanbul, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Izmir Medicalpark Hospital, Izmir, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Birmingham Heartlands Hospital, Birmingham, United Kingdom

    Contact: Study coordinator (Principal Investigator)
  • St James'S University Hospital, Leeds, United Kingdom

    Contact: Study coordinator (Principal Investigator)
  • Churchill Hospital, Oxford, United Kingdom

    Contact: Study coordinator (Principal Investigator)
Study leads
  • Global Clinical Director

    Study Director

    Daiichi Sankyo